RecruitingPhase 3NCT03949049
Citicoline as Neuroprotector in Neonates Exposed to Hypoxia
Efficacy of Citicoline as Neuroprotector in Neonates Exposed to Hypoxia: A Randomized Controlled Trial
Sponsor
Sherief Abd-Elsalam
Enrollment
40 participants
Start Date
Feb 1, 2019
Study Type
INTERVENTIONAL
Conditions
Summary
Citicoline as neuroprotector in neonates exposed to hypoxia: A randomized controlled trial
Eligibility
Max Age: 1 Month
Inclusion Criteria1
- neonates with hypoxia.
Exclusion Criteria1
- hypoxic ischemic encephalopathy
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGCiticoline
Citacoline as neuroprotector
OTHERPlacebo
placebo group
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03949049